ANI
25 Jan 2023, 21:26 GMT+10
New Delhi [India], January 25 (ANI): China needs a good Covid 19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.
Talking to ANI, Poonawalla said, "Covovax is an excellent vaccine against Omicron. We have got a lot of data and global trials for it. It's approved in the US and Europe which no other Indian COVID vaccine has. Let's see how it goes.""We haven't received positive response from China. They need a good booster like our Covovax vaccine which is approved by DCGI and will soon be available on the COVID app," he added.
As per sources, NTAGI is likely to soon meet regarding the inclusion of Covid vaccine Covovax on the CoWIN portal as heterologous booster dose for adults to boost uptake of booster doses.
The Serum Institute of India has also written a letter to the Union Health Ministry seeking inclusion of its Covid vaccine Covovax on the CoWIN portal.
On January 16, Drugs Controller General of India (DCGI) has approved market authorisation for Serum Institute of India (SII) COVID jab Covovax, as heterologous booster dose.
Notably, the government panel of Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as heterologous booster dose for those who have already taken two doses of Covishield or Covaxin.
Adar further said that SII is also working on the Malaria vaccine for Africa. The vaccine for dengue is underway, which is expected in two years. (ANI)Get a daily dose of New York Telegraph news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to New York Telegraph.
More InformationNEW YORK, New York -U.S. stock markets closed with broad gains on Thursday, led by strong performances in U.S. tech stocks, while European...
LONDON/STOCKHOLM: The Persson family is ramping up its investment in the H&M fashion empire, fueling renewed speculation about a potential...
PARIS, France: L'Oréal is making a fresh play in the booming premium haircare segment with a new acquisition. The French beauty conglomerate...
MENLO PARK, California: Robinhood is giving European investors a new way to tap into America's most prominent tech names — without...
NEW YORK, New York - U.S. stocks diverged on Wednesday for the second day in a row. The Standard and Poor's 500 hit a new all-time...
NEW YORK CITY, New York: The U.S. dollar continues to lose ground, weighed down by growing concerns over Washington's fiscal outlook...
NEW YORK CITY, New York: The U.S. dollar continues to lose ground, weighed down by growing concerns over Washington's fiscal outlook...
]LONDON, U.K.: A World Health Organization (WHO) expert group investigating the origins of the COVID-19 pandemic released its final...
Multiple Kiev officials have criticized the halt of US weapon supplies Kiev is no longer a priority at the center of US foreign policy,...
The Obama administrations top spies manipulated the probe from the onset, according to John Ratcliffe A US intelligence report on...
Washington, DC [US], July 2 (ANI): US President Donald Trump was yet again at his rhetoric against the Democratic mayoral nominee for...
The US president has vowed to stop Zohran Mamdani from destroying the city US President Donald Trump has accused Democratic mayoral...